Close Menu

NEW YORK (GenomeWeb) — Luxembourg-based diagnostics firm Advanced Biological Laboratories announced today a collaboration with Mayo Clinic Laboratories to develop a clinical test to detect mutations associated with antiviral resistance in human cytomegalovirus.

The test will leverage next-generation sequencing to sequence PCR amplicons of the UL54 and UL97 genes in which drug resistance with CMV has been associated. ABL's software, DeepChek-CMV, will be used to analyze the data and to interpret possible drug resistance in the virus.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Jun
13

Ribosomal ribonucleic acid (rRNA) accounts for up to 99 percent of the total RNA depending on the cell type. 

Jun
17

This webinar will provide an overview of polygenic risk scores, which aggregate dozens of genetic variants that have been linked to disease risk in genome-wide association studies (GWAS) into a single score.

Jun
18
Sponsored by
ArcherDX

This webinar will discuss background and clinical genomics of NTRK fusion detection in cancer. NTRK fusions are the focus of new therapeutic options, but clonal and subclonal lesions are notoriously difficult to detect.